Nuechterlein Carole (CIK 0001665133)

Latest company ownership

Shares held
60,000
Last filed at
Jun 28, 2024
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Oct 25, 2023 Oct 27, 2023 Aligos Therapeutics, Inc. Director Buy 100.0 +7,933,601 256.56% ✗ $6M